In accord with ASX requirements, Imagion Biosystems’ quarterly financial statement Appendix 4C was lodged with the Australian Securities Exchange on 31 July, 2017, accompanied by commentary on the company’s recent IPO and management’s 12-18 month outlook.
View the Appendix 4C Announcement for Q2, 2017.
[VIDEO] EGM Recording – 13 November 2023
November 14, 2023
https://youtu.be/hThLkmpJPW0 EGM 13 November 2023 Video transcript: Welcome and thanks for joining us. Both those joining virtually and those in person. As the time is